ProCE Banner Activity

FAQs: Advances and Equitable Care in Ovarian Cancer

Clinical Thought

Read experts’ answers to managed care professionals’ questions about recent advances in ovarian cancer care, including delivery of equitable care for all patients.

Released: April 11, 2023

Share

Faculty

Laura R. Bobolts

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth
OncoHealth
Plantation, Florida

Colleen Bohnenkamp

Colleen Bohnenkamp, PharmD, BCOP, BCPS

Oncology Clinical Pharmacist
The University of Kansas Health System
Kansas City, Kansas

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, GSK, Immunogen, Inc., Merck Sharp & Dohme LLC, and Novocure, Inc.

AstraZeneca

GSK

ImmunoGen, Inc.

Merck Sharp & Dohme, LLC

Novocure, Inc

Partners

Clinical Care Options, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth
OncoHealth
Plantation, Florida

Laura R. Bobolts, PharmD, BCOP, has no relevant financial relationships to disclose.

Colleen Bohnenkamp, PharmD, BCOP, BCPS

Oncology Clinical Pharmacist
The University of Kansas Health System
Kansas City, Kansas

Colleen Bohnenkamp, PharmD, BCOP, BCPS, has no relevant financial relationships to disclose.